318 related articles for article (PubMed ID: 38183141)
1. Refining mutanome-based individualised immunotherapy of melanoma using artificial intelligence.
Zakariya F; Salem FK; Alamrain AA; Sanker V; Abdelazeem ZG; Hosameldin M; Tan JK; Howard R; Huang H; Awuah WA
Eur J Med Res; 2024 Jan; 29(1):25. PubMed ID: 38183141
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence and Advanced Melanoma: Treatment Management Implications.
Guerrisi A; Falcone I; Valenti F; Rao M; Gallo E; Ungania S; Maccallini MT; Fanciulli M; Frascione P; Morrone A; Caterino M
Cells; 2022 Dec; 11(24):. PubMed ID: 36552729
[TBL] [Abstract][Full Text] [Related]
3. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction.
Li T; Li Y; Zhu X; He Y; Wu Y; Ying T; Xie Z
Semin Cancer Biol; 2023 Jun; 91():50-69. PubMed ID: 36870459
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence for prediction of response to cancer immunotherapy.
Yang Y; Zhao Y; Liu X; Huang J
Semin Cancer Biol; 2022 Dec; 87():137-147. PubMed ID: 36372326
[TBL] [Abstract][Full Text] [Related]
6. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Sahin U; Derhovanessian E; Miller M; Kloke BP; Simon P; Löwer M; Bukur V; Tadmor AD; Luxemburger U; Schrörs B; Omokoko T; Vormehr M; Albrecht C; Paruzynski A; Kuhn AN; Buck J; Heesch S; Schreeb KH; Müller F; Ortseifer I; Vogler I; Godehardt E; Attig S; Rae R; Breitkreuz A; Tolliver C; Suchan M; Martic G; Hohberger A; Sorn P; Diekmann J; Ciesla J; Waksmann O; Brück AK; Witt M; Zillgen M; Rothermel A; Kasemann B; Langer D; Bolte S; Diken M; Kreiter S; Nemecek R; Gebhardt C; Grabbe S; Höller C; Utikal J; Huber C; Loquai C; Türeci Ö
Nature; 2017 Jul; 547(7662):222-226. PubMed ID: 28678784
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
Sniecinski I; Seghatchian J
Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
[TBL] [Abstract][Full Text] [Related]
8. Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health.
Cheng F; Liang H; Butte AJ; Eng C; Nussinov R
Pharmacol Rev; 2019 Jan; 71(1):1-19. PubMed ID: 30545954
[TBL] [Abstract][Full Text] [Related]
9. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
10. The artificial intelligence and machine learning in lung cancer immunotherapy.
Gao Q; Yang L; Lu M; Jin R; Ye H; Ma T
J Hematol Oncol; 2023 May; 16(1):55. PubMed ID: 37226190
[TBL] [Abstract][Full Text] [Related]
11. Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review.
Luo J; Li X; Wei KL; Chen G; Xiong DD
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12535-12542. PubMed ID: 37389595
[TBL] [Abstract][Full Text] [Related]
12. Advances in artificial intelligence to predict cancer immunotherapy efficacy.
Xie J; Luo X; Deng X; Tang Y; Tian W; Cheng H; Zhang J; Zou Y; Guo Z; Xie X
Front Immunol; 2022; 13():1076883. PubMed ID: 36685496
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
14. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review.
Naseem M; Akhund R; Arshad H; Ibrahim MT
J Prim Care Community Health; 2020; 11():2150132720963634. PubMed ID: 32996368
[TBL] [Abstract][Full Text] [Related]
16. Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination.
Vormehr M; Schrörs B; Boegel S; Löwer M; Türeci Ö; Sahin U
J Immunol Res; 2015; 2015():595363. PubMed ID: 26844233
[TBL] [Abstract][Full Text] [Related]
17. Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer.
Sanchez K; Kamal K; Manjaly P; Ly S; Mostaghimi A
Curr Treat Options Oncol; 2023 Apr; 24(4):373-379. PubMed ID: 36917395
[TBL] [Abstract][Full Text] [Related]
18. Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF.
VerMilyea M; Hall JMM; Diakiw SM; Johnston A; Nguyen T; Perugini D; Miller A; Picou A; Murphy AP; Perugini M
Hum Reprod; 2020 Apr; 35(4):770-784. PubMed ID: 32240301
[TBL] [Abstract][Full Text] [Related]
19. Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Kreiter S; Vormehr M; van de Roemer N; Diken M; Löwer M; Diekmann J; Boegel S; Schrörs B; Vascotto F; Castle JC; Tadmor AD; Schoenberger SP; Huber C; Türeci Ö; Sahin U
Nature; 2015 Apr; 520(7549):692-6. PubMed ID: 25901682
[TBL] [Abstract][Full Text] [Related]
20. Artificial Intelligence and Precision Medicine: Outcome of Immunotherapy in Hepatocellular Carcinoma.
Theodros E; Nagaraju GP
Crit Rev Immunol; 2022; 42(6):1-8. PubMed ID: 37082946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
